Immuno-Cell Therapy Market size is estimated to be USD XX Billion in 2024 and is expected to reach USD YY Billion by 2033 at a CAGR of ZZ% from 2026 to 2033.
Rapid Growth in the Immuno-Cell Therapy Market
South Korea's immuno-cell therapy market is experiencing significant growth, with revenues projected to rise from USD 89.3 million in 2022 to USD 544.2 million by 2030, reflecting a compound annual growth rate (CAGR) of 25.3%.
Dominant Therapy Types
CAR T-Cell Therapy: Leading the market in revenue generation and expected to maintain its dominance through 2030.
Natural Killer (NK) Cell Therapy: Gaining traction due to its potential in targeting cancer cells without prior sensitization.
Dendritic Cell Therapy: Emerging as a personalized approach to cancer immunotherapy.
Industry Requirements and Challenges
Manufacturing Infrastructure: The production of cell therapies requires advanced facilities adhering to Good Manufacturing Practices (GMP). Companies like Samsung Biologics are expanding their capacities to meet these needs.
Regulatory Framework: The Ministry of Food and Drug Safety (MFDS) has stringent regulations, ensuring the safety and efficacy of therapies. However, this can lead to delays in the approval and availability of treatments.
Cost Considerations: High manufacturing costs, especially for personalized therapies, pose challenges for widespread adoption and reimbursement.
Collaborations and Investments
Pharmaceutical companies are entering partnerships to advance research and development. For instance, Daewoong Pharmaceutical has collaborated with UCI Therapeutics to develop CAR-NK cell therapies, highlighting the industry's commitment to innovation.
Future Outlook
With continuous advancements in technology and increasing investments, South Korea's immuno-cell therapy market is poised for substantial growth. The focus remains on enhancing manufacturing capabilities, streamlining regulatory processes, and making therapies more accessible to patients.
Get an In-Depth Research Analysis of the South Korea Immuno-Cell Therapy Market Size And Forecast [2025-2032]
Â
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Immuno-Cell Therapy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Immuno-Cell Therapy Market
T-Cells
B-Cells
NK Cells
Stem Cells
Dendritic Cells
Chimeric Antigen Receptor (CAR) T-Cell Therapy
T-Cell Receptor (TCR) Therapy
Engineered T-Cell Therapy
Immune Checkpoint Inhibitors
Oncolytic Virus Therapy
Oncology
Autoimmune Disorders
Infectious Diseases
Cardiovascular Diseases
Metabolic Disorders
Hospitals
Research Laboratories
Academic Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Autologous Cells
Allogeneic Cells
Synthetic Cells
Stem Cell-Derived Cells
Primary Immune Cells
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Immuno-Cell Therapy Market Research Analysis
1. Introduction of the South Korea Immuno-Cell Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Immuno-Cell Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Immuno-Cell Therapy Market, By Type
6. South Korea Immuno-Cell Therapy Market, By Application
7. South Korea Immuno-Cell Therapy Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Immuno-Cell Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/